Using a modular massively parallel reporter assay to discover context-dependent regulatory activity in type 2 diabetes-linked noncoding regions
Most complex trait association signals reside in the noncoding genome, where defining function is challenging. MPRAs (massively parallel reporter assays) offer a scalable means to test variants' regulatory impacts but are typically cell-type agnostic, pairing cloned fragments with generic "housekeeping" promoters. To explore MPRAs' context sensitivity, we screened a panel of nearly 12,000 fragments across >300 diabetes- and metabolic-trait-associated regions in a pancreatic β cell line model. We compared activity when fragments were placed up- versus downstream of a reporter gene and combined with the synthetic housekeeping promoter super core promoter 1 (SCP1) versus the physiologically relevant human insulin (INS) gene promoter. We identified clear effects of MPRA construct design on regulatory activity. A subset of fragments (n = 702/11,656) displayed positional bias, evenly distributed across up- and downstream preferences. Promoter choice also influenced MPRA activity (n = 698/11,656), mostly biased toward the cell-specific INS promoter (73.4%). A screen for sequence annotations associated with INS promoter preference revealed enrichment for HNF1 binding motifs. HNF1 family transcription factors are key regulators of glucose metabolism disrupted in maturity-onset diabetes of the young (MODY), suggesting genetic convergence between rare coding variants that cause MODY and common type 2 diabetes (T2D)-associated regulatory regions. A follow-up HNF1-focused MPRA highlighted several instances where motif deletion or mutation disrupted regulatory activity specifically in the context of the INS1 promoter and in the β cell model but not in another diabetes-relevant cell type, skeletal muscle. These results identify technical factors that may require careful consideration while designing MPRA experiments.
Authors
- Adelaide Tovar (ORCID: https://orcid.org/0000-0003-1699-7231)
- Arushi Varshney (ORCID: https://orcid.org/0000-0001-9177-9707)
- Kirsten Nishino (ORCID: https://orcid.org/0009-0005-3384-1249)
- Yasuhiro Kyono (ORCID: https://orcid.org/0000-0001-8472-6332)
- Jacob Otto Kitzman (ORCID: https://orcid.org/0000-0002-6145-882X)
- Maya Bose (ORCID: https://orcid.org/0000-0002-4944-6033)
- Stephen Parker
Institutions
- University of Michigan (US)
Publication Details
- Journal
- Human Genetics and Genomics Advances
- Published
- 2026-04-07
- DOI
- https://doi.org/10.1016/j.xhgg.2026.100606
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Burroughs Wellcome Fund
- National Human Genome Research Institute
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases